FDA approves SPEVIGO for generalized pustular psoriasis flares
The U.S. Food and Drug Administration has approved SPEVIGO (spesolimab-sbzo) as the first treatment option for generalized pustular psoriasis (GPP) flares in adults. SPEVIGO is a novel, selective antibody infusion …
FDA approves SPEVIGO for generalized pustular psoriasis flares Read More